Page last updated: 2024-08-24

bromfenac and travoprost

bromfenac has been researched along with travoprost in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Aihara, M; Matsuo, H; Miyata, K; Sakata, R; Sakisaka, T1

Trials

1 trial(s) available for bromfenac and travoprost

ArticleYear
Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution.
    Journal of glaucoma, 2016, Volume: 25, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzophenones; Bromobenzenes; Conjunctiva; Conjunctival Diseases; Double-Blind Method; Female; Humans; Hyperemia; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Time Factors; Travoprost; Young Adult

2016

Other Studies

1 other study(ies) available for bromfenac and travoprost

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013